| Drug General Information |
| Drug ID |
DXU7QZ
|
| Drug Name |
5-Methoxy-1-thiophen-3-yl-1H-benzoimidazole
|
| Synonyms |
CHEMBL358469
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Formula |
C12H10N2OS
|
| Canonical SMILES |
COc1ccc2c(c1)ncn2c3ccsc3
|
| InChI |
InChI=1S/C12H10N2OS/c1-15-10-2-3-12-11(6-10)13-8-14(12)9-4-5-16-7-9/h2-8H,1H3
|
| InChIKey |
XBRXJBQOLZZMNF-UHFFFAOYSA-N
|
| Target and Pathway |
| Target(s) |
Basic fibroblast growth factor receptor 1 |
Target Info |
|
[1]
|
|---|
| Platelet-derived growth factor receptor |
Target Info |
|
[1]
|
|
KEGG Pathway
|
MAPK signaling pathway
|
|
Ras signaling pathway
|
|
Rap1 signaling pathway
|
|
PI3K-Akt signaling pathway
|
|
Adherens junction
|
|
Signaling pathways regulating pluripotency of stem cells
|
|
Regulation of actin cytoskeleton
|
|
Pathways in cancer
|
|
Proteoglycans in cancer
|
|
Prostate cancer
|
|
Melanoma
|
|
Central carbon metabolism in cancer
|
|
NetPath Pathway
|
TCR Signaling Pathway
|
|
PANTHER Pathway
|
Angiogenesis
|
|
FGF signaling pathway
|
|
Pathway Interaction Database
|
Glypican 1 network
|
|
Syndecan-4-mediated signaling events
|
|
N-cadherin signaling events
|
|
FGF signaling pathway
|
|
WikiPathways
|
Regulation of Actin Cytoskeleton
|
|
Endochondral Ossification
|
|
MAPK Signaling Pathway
|
|
Mesodermal Commitment Pathway
|
|
Hair Follicle Development: Induction (Part 1 of 3)
|
|
Integrated Pancreatic Cancer Pathway
|
|
Signaling Pathways in Glioblastoma
|
|
Neural Crest Differentiation
|
|
Signaling by FGFR
|
| References |
| REF 1 | URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017 |
|---|
